Brief: XORTX Files Provisional Patent To Diagnose And Treat Individuals At Risk Of Polycystic Kidney Disease Progression
03/01/2023 13:20
Jan 3 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX FILES NEW PROVISIONAL PATENT TO DIAGNOSE AND TREAT
INDIVIDUALS MOST AT RISK OF POLYCYSTIC KIDNEY DISEASE
PROGRESSION
Source text for Eikon: ID:nGNX47m5YV
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering